GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Catheter Precision
Catheter Precision is a medical device company developing technology to improve cardiac arrhythmia treatment. Its stock price is a bet that its system will become a new standard in electrophysiology.
Share prices of companies in the market segment - Heart
Catheter Precision develops medical devices that help electrophysiologists perform more precise ablation procedures to treat cardiac arrhythmia. We've categorized it under "Heart." The chart below shows how investors rate innovations in cardiac surgery.
Broad Market Index - GURU.Markets
Catheter Precision is a medical device company that develops and markets electrophysiological systems for the treatment of cardiac arrhythmias. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
VTAK - Daily change in the company's share price Catheter Precision
Catheter Precision, Inc.'s daily price change reflects volatility in the medical device sector. The indicator demonstrates sensitivity to sales of its cardiac arrhythmia navigation system.
Daily change in the price of a set of shares in a market segment - Heart
Catheter Precision develops technologies to improve cardiac arrhythmia treatment procedures. The cardiac equipment sector is high-tech and competitive. The graph below shows the average volatility in this niche, allowing one to assess how the market is accepting VTAK's innovations.
Daily change in the price of a broad market stock, index - GURU.Markets
Catheter Precision develops technology to improve cardiac arrhythmia treatments. This innovative medtech company's shares are responding to clinical advances and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Catheter Precision
Catheter Precision, Inc.'s year-over-year performance tells the story of its cardiac arrhythmia treatment technology. Its 12-month market cap growth reflects its success in commercializing its VIVO™ system, which helps electrophysiologists more accurately identify arrhythmia sources, a key to successful ablation procedures.
Annual dynamics of market capitalization of the market segment - Heart
Catheter Precision, as a company developing arrhythmia treatment technology, is betting on medical innovation. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique technology and secure regulatory approval.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Catheter Precision, a medical technology company focused on treating arrhythmia, reflects the complex process of innovation in cardiac surgery. Its ability to stay ahead of the market depends on the success of its technology among physicians and its ability to commercialize it.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Catheter Precision
Catheter Precision is a medical device company developing technology for treating cardiac arrhythmias. Its monthly performance reflects progress in the commercialization of its VIVO system. Key updates include updates on its implementation in leading clinics and procedure data.
Monthly dynamics of market capitalization of the market segment - Heart
The cardiology medical equipment market, particularly for arrhythmia treatment, is a high-tech niche. The dynamics of this sector, shown in the graph, reflect the demand for innovative methods. Companies like Catheter Precision are developing their systems in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Catheter Precision, a cardiology equipment company, is betting on innovation in medical technology. The company's shares are driven by news of its technology implementations rather than by general market trends, creating an independent profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Catheter Precision
Catheter Precision develops technology to improve cardiac arrhythmia treatment. Its weekly stock price performance reflects the implementation of its system in cardiology centers, physician reviews, and news confirming the clinical benefits of its approach.
Weekly dynamics of market capitalization of the market segment - Heart
Catheter Precision has developed a system that helps electrophysiologists more accurately identify areas of the heart that cause arrhythmia. This technology improves the efficiency of surgeries. The chart below shows how the company's stock compares to other major players in the cardiac equipment sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Catheter Precision has developed a system that helps treat arrhythmia. This technology improves the efficiency of surgeries. The chart below shows how the company's stock compares to other cardiac equipment giants and the broader market.
Market capitalization of the company, segment and market as a whole
VTAK - Market capitalization of the company Catheter Precision
Catheter Precision's market capitalization chart reflects investor valuation of its cardiology devices. Its dynamics reflect the market's appreciation of its VIVO and LockeT systems, which assist physicians in treating cardiac arrhythmias. Its low valuation highlights the challenges of commercializing new medical equipment in a competitive market.
VTAK - Share of the company's market capitalization Catheter Precision within the market segment - Heart
Catheter Precision develops technologies for cardiac electrophysiology procedures. Its market share in the medical device sector is small, but it solves an important problem. Its market cap reflects the potential of its VIVO system for non-invasively identifying the source of arrhythmia before surgery.
Market capitalization of the market segment - Heart
This graph shows the overall market capitalization of the entire cardiovascular treatment sector. For Catheter Precision, with its arrhythmia treatment technology, this line is a map of the future of cardiology. The graph's growth reflects how technology enables increasingly precise and safe cardiac interventions, the company's core business.
Market capitalization of all companies included in a broad market index - GURU.Markets
Catheter Precision develops technologies for cardiac electrophysiology procedures, helping treat arrhythmia. Its market capitalization is measured by its precision in cardiac surgery. This represents the market share of the business that makes cardiac surgery safer.
Book value capitalization of the company, segment and market as a whole
VTAK - Book value capitalization of the company Catheter Precision
Catheter Precision develops technologies for cardiac electrophysiology procedures. Its book value is derived from its intellectual property (patents for navigation systems) and financial resources. This is its capital for improving precision in cardiac surgery. How has this changed? The chart below shows.
VTAK - Share of the company's book capitalization Catheter Precision within the market segment - Heart
Catheter Precision, Inc. develops electrophysiological systems for the treatment of arrhythmia. Its business requires manufacturing capacity to assemble its VIVO navigation systems and disposable components. The chart shows its share of the physical infrastructure required to manufacture high-tech cardiac equipment.
Market segment balance sheet capitalization - Heart
Catheter Precision is a medical technology company. This sector, as the chart shows, is capital-intensive. Catheter Precision has developed a unique system, and its capital is invested in the R&D and production of this complex product.
Book value of all companies included in the broad market index - GURU.Markets
Catheter Precision's assets are not pacemakers, but rather equipment and software that help electrophysiologists obtain more accurate "maps" of the heart for arrhythmia treatment. Its book value reflects its technological potential in this complex field of medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Catheter Precision
Catheter Precision is a medical technology company developing navigation systems for arrhythmia treatment. Its market value is determined by its technology and its potential to make complex cardiac procedures more precise and safe.
Market to book capitalization ratio in a market segment - Heart
Catheter Precision is developing technology to improve cardiac arrhythmia treatment procedures. The chart shows how investors view its innovations and their potential to make complex cardiac surgeries safer and more effective.
Market to book capitalization ratio for the market as a whole
Catheter Precision develops technologies to improve cardiac arrhythmia treatments. The company's value lies in its ability to make complex medical interventions safer and more effective. This chart shows how investors value innovation in medical devices.
Debts of the company, segment and market as a whole
VTAK - Company debts Catheter Precision
Catheter Precision, a company developing navigation systems for treating cardiac arrhythmias, is raising capital to commercialize its technology. This chart shows the financial costs of bringing complex medical equipment to market, which requires physician training and integration into clinical practice.
Market segment debts - Heart
Catheter Precision develops and markets electrophysiology systems that help physicians more accurately perform procedures to treat cardiac arrhythmias. This chart illustrates how the medical technology company is funding the R&D and commercialization of its high-tech systems, aiming to improve patient outcomes in the complex field of cardiology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Catheter Precision
Catheter Precision develops technologies for cardiac electrophysiology procedures, helping doctors more accurately pinpoint areas causing arrhythmia. Bringing complex medical equipment to market requires significant R&D and clinical trials. This chart shows how the company uses debt to finance its cardiology innovations.
Market segment debt to market segment book capitalization - Heart
Catheter Precision develops technologies to improve cardiac arrhythmia treatments. This is a high-tech segment of medicine. This chart shows how the company finances its research and development and commercialization. It compares its debt load to the overall medical device sector's market capitalization, reflecting its financial risks.
Debt to book value of all companies in the market
Catheter Precision develops technologies for more precise procedures to treat cardiac arrhythmia. Medical innovations require significant and long-term capital investment. Does the company use debt for its R&D? This chart of total market debt provides context for assessing its financial strength.
P/E of the company, segment and market as a whole
P/E - Catheter Precision
Catheter Precision is a medical technology company developing systems to improve cardiac arrhythmia treatment. This chart shows how investors value its innovative electrophysiology solutions. This value is based on the adoption of its technologies by cardiologists.
P/E of the market segment - Heart
Catheter Precision develops and markets electrophysiology systems that help physicians navigate the heart during arrhythmia treatment procedures. This chart illustrates the average rating in the cardiac medical equipment sector, where precision, safety, and improved procedural outcomes are valued.
P/E of the market as a whole
Catheter Precision, Inc. is a medical technology company that develops and markets electrophysiological systems to aid in the treatment of cardiac arrhythmias. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether VTAK's valuation reflects faith in its cardiac treatment products or whether it is moving in line with overall industry trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Catheter Precision
Catheter Precision develops medical devices that help doctors navigate the heart during arrhythmia treatment procedures. Their technology is designed to make surgeries more precise and safe. This chart reflects market expectations for the future implementation of their navigation systems in electrophysiology labs worldwide.
%20P%2FE%20Catheter%20Precision&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Catheter-Precision&v=1772615359231 "Chart of the company's future (projected) P/E Catheter Precision")
Future (projected) P/E of the market segment - Heart
Catheter Precision develops medical devices that help doctors perform more precise ablation procedures to treat cardiac arrhythmias. The chart reflects future revenue forecasts for the sector, helping to understand the market's confidence in the company's technology becoming the new standard in electrophysiology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772615359243 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
Catheter Precision develops medical equipment that helps doctors more accurately treat cardiac arrhythmias. This chart of overall healthcare sentiment reflects investor confidence in the potential of technologies that improve the precision and safety of complex medical interventions.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772615359254 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Catheter Precision
Catheter Precision develops and markets electrophysiology systems that help doctors perform more precise ablation procedures to treat cardiac arrhythmias. Revenue depends on the adoption of its technology in hospitals. This chart shows how the company is monetizing the need for increased precision and safety in cardiac surgery.
Profit of companies in the market segment - Heart
Catheter Precision, Inc. is a medical technology company that has developed a system that helps doctors more accurately locate arrhythmias in the heart during ablation procedures. This graph shows overall profitability in the cardiac care sector, where improving the precision and safety of cardiac procedures is critical.
Overall market profit
Catheter Precision, Inc. develops medical devices for the treatment of cardiac arrhythmias. Demand for these vital technologies is driven by healthcare needs, not economic conditions. The company's growth depends on innovation and its implementation in clinical practice, not on the macroeconomic trends visible in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Catheter Precision
Catheter Precision develops medical devices that help doctors locate the sources of cardiac arrhythmias during ablation procedures. Future revenue depends on the adoption of its technology by electrophysiologists. This chart reflects analysts' expectations for its contribution to improving arrhythmia treatment outcomes.
%20profit%20of%20the%20company%20Catheter%20Precision&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Catheter-Precision&v=1772615359413 "Graph of future (projected) profit of the company Catheter Precision")
Future (predicted) profit of companies in the market segment - Heart
Catheter Precision develops technologies for electrophysiology procedures, helping physicians more accurately identify and treat cardiac arrhythmias. Its VIVO system aims to improve ablation results. This graph shows profitability expectations for the cardiac equipment sector, helping to evaluate Catheter Precision's innovations.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772615359528 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
Catheter Precision is developing technology to improve cardiac arrhythmia treatment. The company's success depends on the acceptance of its system by hospitals and surgeons. This economic outlook impacts healthcare system budgets and their willingness to invest in new, high-tech medical equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772615359581 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Catheter Precision
Catheter Precision is developing technology to improve cardiac arrhythmia treatments. At the commercialization stage, revenue is a key indicator of market adoption. This chart shows how investors assess its potential to improve the precision and safety of cardiac surgery.
P/S market segment - Heart
Catheter Precision develops and markets electrophysiology systems that help physicians perform ablation procedures more accurately and safely to treat cardiac arrhythmias, such as atrial fibrillation. This chart reflects the average revenue estimate for the sector, helping to assess how the market perceives their innovative technologies in cardiology.
P/S of the market as a whole
Catheter Precision develops medical devices that help doctors navigate the heart during arrhythmia treatments. This graph, which shows the company's average revenue estimate, helps us understand the premium investors place on technologies that improve the precision and safety of complex medical procedures.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Catheter Precision
Catheter Precision develops medical equipment to improve cardiac arrhythmia treatment. Its technology helps doctors more accurately identify areas of the heart requiring intervention. Estimating future revenue is important for such a company, as it reflects investors' perception of its technology's potential to become a standard in electrophysiology and improve patient outcomes.
%20P%2FS%20Catheter%20Precision&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Catheter-Precision&v=1772615359861 "The graph of the company's future (projected) P/S Catheter Precision")
Future (projected) P/S of the market segment - Heart
Catheter Precision develops technologies for cardiac electrophysiology procedures, helping doctors perform more precise ablation procedures to treat arrhythmias. This chart compares the company's estimated future sales with expectations for the medical device sector. It shows whether investors believe its navigation systems will improve treatment outcomes for patients with atrial fibrillation.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772615359878 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
Catheter Precision develops technologies that help physicians navigate the heart during arrhythmia treatment procedures. The company's growth depends on the adoption of its VIVO system in electrophysiology labs. This graph of overall investor expectations reflects their belief that medical technology can improve the precision and safety of complex procedures.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772615359891 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Catheter Precision
This chart shows Catheter Precision's revenue from sales of its VIVO system for non-invasive arrhythmia source determination prior to catheter ablation. Revenue growth will depend on the adoption of this innovative technology in electrophysiology laboratories worldwide.
Sales of companies in the market segment - Heart
Catheter Precision has developed the VIVO system, which helps physicians more accurately identify arrhythmia sources before ablation procedures. As its commercialization progresses, its revenue structure will reflect the proportion of sales coming from the system itself and the proportion from disposable consumables.
Overall market sales
Catheter Precision, Inc. has developed technology to more accurately identify the sources of cardiac arrhythmias during ablation procedures. The company aims to improve treatment outcomes. This overall economic outlook does not diminish the need for advanced medical technologies that can save lives and improve the quality of life for patients with heart disease.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Catheter Precision
Catheter Precision develops medical devices that help electrophysiologists more accurately perform ablation procedures to treat cardiac arrhythmias, such as atrial fibrillation. Future revenue depends on the adoption of its technology in hospitals. This chart reflects analysts' expectations for demand for innovative instruments in cardiac surgery.
%20sales%20of%20the%20company%20Catheter%20Precision&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Catheter-Precision&v=1772615359931 "Schedule of future (projected) sales of the company Catheter Precision")
Future (projected) sales of companies in the market segment - Heart
Catheter Precision develops technologies to improve cardiac arrhythmia treatment procedures. This chart illustrates the forecast for the cardiac equipment market. Is demand growing for high-precision systems that improve the effectiveness and safety of arrhythmia interventions? This reflects the overall trend in medical equipment development.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772615359932 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
Catheter Precision develops medical devices for electrophysiological procedures used to treat cardiac arrhythmia. Demand for its products depends on the number of procedures performed and the introduction of new technologies in cardiology. This overall economic activity is of secondary importance to the company compared to healthcare system factors.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772615359936 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Catheter Precision
Catheter Precision develops medical devices that help physicians navigate the heart during arrhythmia treatment procedures. This chart shows the company's financial trajectory during the commercialization phase. Profitability depends on the adoption of its technologies by electrophysiologists and proof that they improve the safety and effectiveness of ablation.
Market segment marginality - Heart
Catheter Precision, Inc. develops and markets medical devices that help electrophysiologists more accurately perform procedures to treat cardiac arrhythmias. This chart reflects the company's financial performance at the commercialization stage, where profitability depends on the adoption of its technology in hospitals and clinics.
Market marginality as a whole
Catheter Precision develops technologies to improve cardiac arrhythmia treatment procedures. Its success depends on the acceptance of its systems by cardiologists. This overall return chart reflects the state of the healthcare system and its willingness to invest in equipment that can improve the precision and safety of complex medical interventions.
Employees in the company, segment and market as a whole
Number of employees in the company Catheter Precision
Catheter Precision develops medical systems that help doctors navigate the heart during arrhythmia treatment procedures. Its team of engineers and clinicians is key to its success. This chart shows how the company is expanding its commercial and technical staff to bring its innovative products to the cardiac equipment market.
Share of the company's employees Catheter Precision within the market segment - Heart
Catheter Precision develops technologies that help doctors navigate the heart during arrhythmia treatments. Creating such complex medical equipment requires a team of engineers and programmers. This graph shows the company's market share, reflecting its technological expertise and product commercialization efforts.
Number of employees in the market segment - Heart
Catheter Precision develops technologies to improve electrophysiological studies and ablation procedures for the treatment of cardiac arrhythmias. The chart shows employment in the cardiology sector. The company's systems help physicians more accurately identify and eliminate arrhythmia sources, increasing the success of procedures.
Number of employees in the market as a whole
Catheter Precision develops technologies to improve cardiac arrhythmia treatment procedures. The company's growth depends on the implementation of its innovations in cardiology practice. This chart shows overall employment, and Catheter Precision is an example of how MedTech companies are creating high-tech jobs aimed at improving the precision and safety of medical interventions.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Catheter Precision (VTAK)
Catheter Precision is a medical technology company that developed the VIVO system for non-invasive 3D mapping of cardiac arrhythmias. This is high-tech R&D. This graph shows the high market value the market attributes to their innovative technology. It reflects the value of their intellectual capital per engineer.
%20of%20the%20company%20Catheter%20Precision%20(VTAK)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Catheter-Precision-VTAK&v=1772615360049 "Chart of market capitalization per employee (in thousands of dollars) of the company Catheter Precision (VTAK)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
Catheter Precision (VTAK) has developed the VIVO system for non-invasively identifying the source of cardiac arrhythmias before ablation procedures. In cardiology, this parameter reflects the value of their diagnostic technology. The high capitalization per employee may indicate that their system is capable of making complex cardiac procedures faster, safer, and more effective.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772615360053 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
Catheter Precision develops medical devices for more precise treatment of cardiac arrhythmias. In the MedTech sector, innovation is key. The graph shows a high employee rating, as its technology can improve the outcomes of complex cardiac procedures, making it a valuable tool for electrophysiologists.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772615360055 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Catheter Precision (VTAK)
Catheter Precision is a company that produces medical equipment (VIVO) that helps doctors navigate the heart during arrhythmia treatments. This is MedTech R&D. This chart shows the company's commercialization stage. The loss per employee reflects investments in R&D and marketing to promote this technology.
%20Chart%20Catheter%20Precision%20(VTAK)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Catheter-Precision-VTAK&v=1772615360096 "Company Profit Per Employee (in thousands of dollars) Chart Catheter Precision (VTAK)")
Profit per employee (in thousands of dollars) in the market segment - Heart
Catheter Precision, Inc. develops technologies to improve cardiac arrhythmia treatment procedures. In the high-tech cardiac equipment industry, employee productivity reflects the value of their innovations. This chart shows the financial return generated by the team creating tools that can improve the precision and safety of complex medical interventions.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772615360141 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
Catheter Precision is a medtech company focused on arrhythmia. They developed a system (VIVO) for non-invasive 3D cardiac mapping to assist surgeons before surgery. They are a B2B medtech company. This graph shows how niche medical software/hardware, where value is created by algorithms, compares in terms of staff efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772615360156 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Catheter Precision (VTAK)
Catheter Precision develops medical devices for the treatment of cardiac arrhythmias. This graph shows the path to commercialization of their innovative technology. A sharp increase in revenue per employee will indicate successful implementation of their systems in hospitals, enabling a small team to generate significant revenue.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Catheter-Precision-VTAK&v=1772615360199 "Sales chart per company employee Catheter Precision (VTAK)")
Sales per employee in the market segment - Heart
Catheter Precision (VTAK) is a medical technology company that developed VIVO, a 3D visualization system that helps doctors non-invasively identify arrhythmia sources before surgery. This graph shows the average output in the sector. For VTAK, this is an indicator of how productive their R&D and sales teams are in promoting this diagnostic software.
Sales per employee for the market as a whole
Catheter Precision (VTAK) is a medical device company. Their VIVO system helps doctors non-invasively identify sources of cardiac arrhythmia before surgery. This indicator demonstrates how effective their R&D and sales team are in promoting this sophisticated device.
Short shares by company, segment and market as a whole
Shares shorted by company Catheter Precision (VTAK)
Catheter Precision (VTAK) develops medical equipment for more precise treatment of cardiac arrhythmia. This chart shows the volume of bearish bets. The shorts may be due to skepticism that the company's technology significantly outperforms existing systems from giants like J&J or Abbott.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Catheter-Precision-VTAK&v=1772615360263 "Short Shares Chart for the Company Catheter Precision (VTAK)")
Shares shorted by market segment - Heart
Catheter Precision (VTAK) has developed the VIVO (View Into Ventricular Onset) system, which helps electrophysiologists more accurately identify the sources of cardiac arrhythmia. This chart shows the overall shortfall in the medical devices sector, highlighting investor concerns about the slow adoption of new technologies in clinics.
Shares shorted by the overall market
Catheter Precision develops navigation systems for the treatment of cardiac arrhythmia. This is complex medical technology that requires FDA approval and, more importantly, hospital acceptance. This chart reflects the general fear. When investors are afraid, they expect clinics to freeze capital expenditures on new expensive equipment. This slows VTAK's commercialization and puts pressure on the stock.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Catheter Precision (VTAK)
This chart shows the market reaction to Catheter Precision technology. The company produces a medical device (VNScope) that helps cardiac surgeons avoid nerve damage during arrhythmia ablation. News of FDA approval or the launch of sales in major hospitals triggers an "overbought" (above 70) market. Slow adoption by surgeons leads to an "oversold" (below 30) market.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Catheter-Precision-VTAK&v=1772615360322 "RSI 14 indicator chart for the company's stock Catheter Precision (VTAK)")
RSI 14 Market Segment - Heart
Catheter Precision is a medical technology company focused on cardiology. They developed the VNScope system, which helps surgeons (electrophysiologists) accurately identify and treat arrhythmia sources. This graph measures the overall momentum in the cardiac medical equipment sector, helping to assess whether this entire innovative segment is overheating.
RSI 14 for the overall market
Catheter Precision, a cardiac equipment company, solves critical healthcare challenges. Despite stable demand for such technologies, the company's shares remain part of the overall market. This indicator helps understand when the overall market is "overheated" (euphoria) or "cooled" (panic). These cycles influence the valuations of even non-cyclical companies like VTAK and determine overall risk appetite.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VTAK (Catheter Precision)
Catheter Precision is a medical technology company that developed VIVO (3D mapping), a non-invasive system that helps doctors accurately identify the source of cardiac arrhythmia before surgery. This chart shows the speculative average 12-month price target from analysts, based on their belief in the adoption of this technology in clinics.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VTAK-Catheter-Precision&v=1772615360399 "A chart showing analyst consensus forecasts for the expected stock price. VTAK (Catheter Precision)")
The difference between the consensus estimate and the actual stock price VTAK (Catheter Precision)
Catheter Precision is a medical technology company whose "map" (VIVO) helps cardiac surgeons *non-invasively* (before surgery) identify sources of arrhythmia (AF). This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their confidence in the implementation of this "preparatory" technology in clinics.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VTAK-Catheter-Precision&v=1772615360415 "A chart showing the difference between the consensus forecast and the actual stock price. VTAK (Catheter Precision)")
Analyst consensus forecast for stock prices by market segment - Heart
Catheter Precision is a MedTech company that created a "heart map." The company produces a system (VIVO) that helps cardiac surgeons "see" the source of arrhythmia before surgery. This chart reflects analysts' general expectations for the entire cardiac pharma (and MedTech) sector. It shows whether experts believe in the growth of "smart" diagnostics.
Analysts' consensus forecast for the overall market share price
Catheter Precision is a medical device company that developed a system (VNScope) that helps surgeons "see" and navigate during cardiac procedures (arrhythmia treatment). This chart shows overall market sentiment. For VTAK, whose business is selling expensive equipment, the overall optimism (the rising chart) is important because it reflects hospitals' readiness for capital expenditures.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Catheter Precision
Catheter Precision is a map for the heart. Their signature feature is software (VIVO) that analyzes a patient's CT/MRI scans before surgery and creates a 3D map of the heart to help the surgeon find the source of arrhythmia (AF). This graph summarizes their implementation history and reflects their (slow) journey to convincing hospitals that their preoperative software improves outcomes.
AKIMA Market Segment Index - Heart
Catheter Precision is a medical device company whose VIVO technology helps surgeons accurately identify the source of cardiac arrhythmia during surgery. This advances precision in cardiac surgery. This graph compares their composite index to the sector, showing how their innovative cardiology equipment outperforms the competition.
The AKIM Index for the overall market
Catheter Precision is a MedTech company developing technologies for the treatment of cardiac arrhythmias (VIVO), assisting in ablation procedures. This chart, reflecting the market average, is a backdrop. It helps assess how VTAK, which strives to improve cardiology precision, compares to overall macroeconomic trends.
